Last reviewed · How we verify
NCT02517931
Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Emergency Department
NA trial testing Sphenopalatine Ganglion Block in Postdural Puncture Headache. Withdrawn.
23 September 2019
Quick facts
| Lead sponsor | University of Arkansas |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | other |
| Start date | 1 January 2019 |
| Primary completion | 23 September 2019 |
| Estimated completion | 23 September 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Sphenopalatine Ganglion Block — full drug profile →
- Placebo
Conditions studied
- Postdural Puncture Headache — all drugs for Postdural Puncture Headache →
Sponsor
University of Arkansas
Who can join
18 and older, any sex, with Postdural Puncture Headache. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates sphenopalatine ganglion block (SPGB) for the treatment of postdural puncture headache (PDPH) in the emergency department (ED). Half of the patients will receive a true nerve block with lidocaine and bupivacaine. The other half will receive a placebo nerve block.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02517931
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sphenopalatine Ganglion Block
Trials testing the same drug.
- NCT07060586 — The Effect of Sphenopalatine Ganglion Block on Headache and Vasalgia · NA · completed
- NCT06933680 — Sphenopalatine Ganglion Block in Bimaxillary Orthognathic Surgery · NA · recruiting
- NCT06157970 — Sphenopalatine Ganglion Block in Septorhinoplasty · completed
- NCT04657952 — Sphenopalatine Ganglion Block for Post-Dural Puncture Headache in Orthopedic Patients · Phase 4 · unknown
Other recruiting trials for Postdural Puncture Headache
Currently open trials in the same condition.
- NCT07075874 — Neutrophil to Lymphocyte Ratio and Postdural Headache · recruiting
Other University of Arkansas trials
Trials by the same sponsor.
- NCT07029776 — MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma · Phase 2 · not yet recruiting
- NCT07341399 — Essential Amino Acid Supplementation in Adult Spinal Deformity Patients · NA · not yet recruiting
- NCT07071766 — Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment · NA · recruiting
- NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
- NCT06604065 — Essential Amino Acids and Parkinsons Disease · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02517931 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Arkansas
- Last refreshed: 25 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02517931.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing